Abstract:MicroRNAs (miRNAs) are 19-25 nucleotides non-coding RNAs that control diverse cellular events through multiple target mRNAs. Dysregulation of specific spectrum of miRNAs in human malignancies is frequently observed, suggesting that they may play a new layer of regulation as oncogenes or tumor suppressors. Apart from the functional role in embryonic development and tumorigenesis, the imprinted H19 gene also exerts as a primary source for miR-675 biosynthesis. As detected by quantitative real-time PCR, both H19 and miR-675 were overexpressed in human colon cancer cell lines (CloneA, MIP101 and SW480) as well as in primary human colorectal cancer tissues; the miR-675 level is positively correlated with the H19 expression level. Ectopic H19 expression by transfection with H19 expression plasmid induced miR-675 expression while H19 knockdown by using H19 siRNA decreased miR-675 expression in colon cancer cells. For biological function of miR-675, ectopic miR-675 expression by transfection with miR-675 precursor increased cell proliferation and anchorage-independent growth of colon cancer cells while miR-675 knockdown by using miR-675 inhibitor suppressed the growth of cells. Moreover, miR-675 overexpression decreased the luciferase activity of a reporter construct comprising the 3\#8217;untranslated region (3\#8217;UTR) of the Rb mRNA. By Western blot analysis, miR-675 overexpression also suppressed RB protein level in cells. These data show, for the first time, that H19-derived miR-675 is involved in colorectal cancer development and may serve as the potential therapeutic targets for colorectal cancer. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 2532.

Tumour-suppressor Activity of H19 RNA

Oncofetal H19-Derived Mir-675 Regulates Tumor Suppressor Rb In Human Colorectal Cancer

H19-Derived Mir-675 Functions As An Oncogenic Microrna In Human Colorectal Cancers Through Targeting The Rb Tumor Suppressor

Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR

Imprinting of Human H19: Allele-Specific CpG Methylation, Loss of the Active Allele in Wilms Tumor, and Potential for Somatic Allele Switching.

Epigenetic Lesions at the H19 Locus in Wilms' Tumour Patients

CRISPR/Cas9 small promoter deletion in H19 lncRNA is associated with altered cell morphology and proliferation

H19 Inhibits RNA Polymerase II-mediated Transcription by Disrupting the Hnrnp U–actin Complex

The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory

H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer

Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors

Promotive effect of long non-coding RNA H19 on the proliferation of gastric cancer MGC-803 cells

Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis

Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways

Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases

The 5' part of the human H19 RNA contains cis-acting elements hampering its translatability

Unique expression patterns of H19 in human testicular cancers of different etiology

RNA Silencing Suppressor P19 Regulates the Expressions of Cell Cycle Related Genes

H19 Gene Overexpression In Atypical Multidrug-Resistant Cells Associated With Expression Of A 95-Kilodalton Membrane Glycoprotein

Inhibition of Mtorc1 by Lncrna H19 Via Disrupting 4E-Bp1/raptor Interaction in Pituitary Tumours

H19 Promotes Endometrial Cancer Progression by Modulating Epithelial-Mesenchymal Transition.